Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 January 2018 Photo Charl Devenish
Researcher tackling drug-resistant TB through molecular methods
Dr Anneke van der Spoel van Dijk is invested in contributing to the global effort of stopping TB by 2035.

The work of Dr Anneke van der Spoel van Dijk investigates the spread of TB in the Free State population using techniques such as next generation sequencing, spoligotyping and MIRU-VNTR typing. Dr Van der Spoel van Dijk, a senior medical scientist in the Department of Medical Microbiology at the University of the Free State (UFS) also looks at drug resistance in her research. This work informs decisions about how best to treat patients with multidrug-resistant TB (MDR-TB). 

She employs rapid molecular techniques to track one of Africa’s most serious diseases, tuberculosis (TB). 

Drug resistance
Scientists assist the National Health Laboratory Service and Department of Health in trying to refine the diagnostic tools to identify these cases earlier. Dr Van der Spoel van Dijk explains: “Until recently, it took up to two years to fine-tune treatment decisions for patients with MDR-TB. Patients get a cocktail of anti-TB drugs, but it takes time to find the right combination. Re-infection and relapse (patients stopping treatment for several reasons) add to the diagnostic and treatment management challenges.

Enormous impact
“Now doctors can reduce the time needed for diagnostic certainty to about seven days, while new drugs allow reduction of treatment from more than 18 to nine months. This can have an enormous impact on the life of many patients.”

Dr Van der Spoel van Dijk’s work forms part of research in the faculty looking at resistance development in TB strains. She is currently also doing her doctoral thesis on the differences and incidence of MDR-TB among adolescents versus adults. Dr Van der Spoel van Dijk says: “It is a complicated picture, but we hope to unravel it to support better diagnostic tools and patient care.”

As part of the National Health Laboratory Service, her department is playing an important role in TB diagnostics and the training of scientists and future pathologists. “Our work is contributing to the global vision to stop TB by 2035,” Dr Van der Spoel van Dijk says.

News Archive

Award-winning artist Mohau Modisakeng exhibits at UFS
2017-03-02

Description: Mohau Modisakeng exhibition 2 Tags: Mohau Modisakeng exhibition 2

One of the artworks from Modisakeng’s Lefa La Ntate
collection.
Photo: Supplied

Standard Bank Young Artist, Mohau Modisakeng is a multidisciplinary artist who uses memory as a portal linking the past and present to explore themes within the post-apartheid context.

The University of the Free State (UFS) is hosting the Visual Arts 2016 artist’s exhibition, entitled Lefa La Ntate. The exhibition is on at the Johannes Stegmann Art Gallery in the Sasol Library on the Bloemfontein Campus and will run until 31 March 2017.

Artist uses his body to explore influences
Lefa La Ntate represents an emotional moment of grieving and is a critical response to the historical legacy of exploitation and the current lived experience of many black South Africans.  

Modisakeng, who was born in Soweto in 1986, uses his body to explore the influence of South Africa’s violent history on how we understand our cultural, political, and social roles as human beings. “My work responds to the history of the black body within the (South) African context, which is intertwined with the violence of the apartheid era and the early 1990s.”

Acknowledging upcoming young artists
The Young Artist Awards were established to acknowledge emerging young South African artists who have displayed outstanding talent in their artistic endeavours.

The exhibition premiered at the National Arts Festival in Grahamstown in 2016 and has travelled to Port Elizabeth, Pietermaritzburg, and Cape Town.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept